In recent years, the diagnostic work‐up for prostate cancer (PCa) has emerged to incorporate the routine use of multiparametric magnetic resonance imaging (mpMRI) in men with an elevated prostate specific antigen (PSA) level.1 This evidence concerns the gene KLK3 and posterior cortical atrophy.